Research Area

Drug Development & Bioanalysis

PK assays, immunogenicity testing, therapeutic drug monitoring, bioanalytical method development, gene therapy research, and HTS screening.

Overview
Drug development and bioanalysis reagents support the therapeutic pipeline — pharmacokinetics, immunogenicity (anti-drug and neutralizing antibodies), therapeutic drug monitoring, bioanalytical method development, and gene-therapy research. From ligand-binding-assay reagents and biosimilar-target antibodies to AAV and lentiviral vectors for CRISPR and knockdown studies, every product is Research Use Only with validation data for regulated bioanalysis.
Product types6
Disease categories7
Biology subfields13
Vetted suppliers
CoA, SDS & validation on every product

What you can study

Each category maps to a filtered view of the domain collection. Representative targets are listed for entity-level discovery — jump straight to the reagents for a specific analyte.

01

Pharmacokinetics (PK)

products

Drug exposure, clearance, and PK/PD bioanalysis.

Representative targets
Explore Pharmacokinetics (PK)
02

Drug Immunogenicity

products

Anti-drug-antibody and neutralizing-antibody assessment.

Representative targets
Explore Drug Immunogenicity
03

Therapeutic Drug Monitoring

products

Therapeutic drug levels for dosing optimization.

Representative targets
Explore Therapeutic Drug Monitoring
04

Bioanalytical Method Development

products

Assay development and validation for biomarker and PK quantification.

Representative targets
Explore Bioanalytical Method Development
05

Gene Therapy & Delivery

products

Viral-vector and genome-editing tools for gene therapy.

Representative targets
Explore Gene Therapy & Delivery
06

HTS & Screening

products

High-throughput screening readouts and potency metrics.

Representative targets
Explore HTS & Screening
07

ADME & Drug Metabolism

products

Absorption, metabolism, and drug-transporter biology.

Representative targets
Explore ADME & Drug Metabolism

Shop this domain by product type

Filtered to Drug Development & Bioanalysis — the high-intent paths to specific reagents.

Frequently asked

Drug Development & Bioanalysis — common questions

Do you support anti-drug-antibody (ADA) assays?
Yes — biosimilar-target antibodies and reagents for ADA and neutralizing-antibody assays against adalimumab, infliximab, and trastuzumab.
What reagents support therapeutic drug monitoring?
Assays and antibodies for infliximab, adalimumab, vedolizumab, and small-molecule drugs to support TDM research.
Do you offer gene-therapy vectors?
AAV and lentiviral vectors plus CRISPR reagents for gene-therapy and genome-editing research, off-the-shelf or custom.

Scale up your Drug Development & Bioanalysis work

Bioanalytical and gene-therapy programs often need custom ADA reagents or vector packaging — talk to a scientist about assay validation and scale.